Burren Capital Advisors Ltd Has $560,000 Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)

Key Points

• Burren Capital Advisors Ltd reduced its stake in Amedisys, Inc. by 73.8% in the first quarter, now holding 6,044 shares valued at approximately $560,000.
• Various institutional investors increased their stakes in Amedisys, with Hexagon Capital Partners raising its position by 108.1% during the same quarter.
• Amedisys reported a quarterly EPS of $1.25, surpassing estimates, while revenue increased 4.1% year-over-year despite falling slightly short of expectations.

Burren Capital Advisors Ltd trimmed its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 73.8% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,044 shares of the health services provider's stock after selling 17,000 shares during the period. Amedisys makes up about 2.0% of Burren Capital Advisors Ltd's portfolio, making the stock its 15th largest holding. Burren Capital Advisors Ltd's holdings in Amedisys were worth $560,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in AMED. Raymond James Financial Inc. acquired a new stake in Amedisys in the fourth quarter worth approximately $215,000. KLP Kapitalforvaltning AS acquired a new stake in Amedisys in the fourth quarter worth approximately $590,000. Vanguard Group Inc. lifted its position in shares of Amedisys by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 3,216,120 shares of the health services provider's stock valued at $291,992,000 after acquiring an additional 10,817 shares during the last quarter. Norges Bank bought a new stake in shares of Amedisys during the 4th quarter worth $83,061,000. Finally, Highbridge Capital Management LLC boosted its stake in shares of Amedisys by 18.0% during the 4th quarter. Highbridge Capital Management LLC now owns 381,123 shares of the health services provider's stock worth $34,602,000 after acquiring an additional 58,223 shares in the last quarter. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Wall Street Zen downgraded Amedisys from a "strong-buy" rating to a "buy" rating in a report on Saturday, May 24th. Royal Bank Of Canada restated an "outperform" rating and set a $100.00 price objective on shares of Amedisys in a report on Wednesday, April 16th.

Amedisys Stock Up 0.8%

Shares of AMED traded up $0.81 during mid-day trading on Wednesday, reaching $98.33. The company's stock had a trading volume of 531,400 shares, compared to its average volume of 358,376. The company has a market cap of $3.23 billion, a price-to-earnings ratio of 36.28, a price-to-earnings-growth ratio of 1.32 and a beta of 0.94. The business has a fifty day moving average of $96.45 and a 200 day moving average of $94.04. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.27. Amedisys, Inc. has a 1 year low of $82.15 and a 1 year high of $98.62.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The health services provider reported $1.54 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.15. Amedisys had a return on equity of 12.52% and a net margin of 3.79%. The firm had revenue of $621.86 million for the quarter, compared to analyst estimates of $614.61 million. During the same period in the previous year, the firm earned $0.98 earnings per share. Amedisys's quarterly revenue was up 5.2% on a year-over-year basis. As a group, analysts forecast that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.